Search
Search Results
-
Is a minimum duration of 5 days of unfractionated heparin infusion necessary before transition to oral anticoagulation in cerebral venous thrombosis? a retrospective chart review
In managing cerebral venous sinus thrombosis (CVT), the standard approach has been administering parenteral anticoagulation for at least five days,...
-
Upstream anticoagulation in patients with ST-segment elevation myocardial infarction: a systematic review and meta-analysis
Background and aimParenteral anticoagulation is recommended for all patients presenting with ST-segment elevation myocardial infarction (STEMI)...
-
Perioperative Anticoagulation in Patients with Cancer
Purpose of ReviewThere is a paucity of evidence for managing perioperative anticoagulation in patients with cancer. This review aims to provide...
-
Between a rock and a hard place: anticoagulation management for ECMO
Anticoagulation is an essential component of optimal extracorporeal membrane oxygenation (ECMO) management. Unfractionated heparin is still the...
-
Parenteral Anticoagulation and Retroperitoneal Hemorrhage in COVID-19: Case Report of Five Patients
Since coronavirus disease 2019 (COVID-19) is associated with a hypercoagulable state, especially in critical patients, anticoagulation is used for...
-
Kee** prior anticoagulation treatment in the acute phase of ischaemic stroke: the REKOALA study
IntroductionA consensus on the management of anticoagulated patients in the acute phase of ischaemic stroke has not yet been established. We aimed to...
-
Anticoagulation Strategies in Temporary Mechanical Circulatory Support
Purpose of reviewSystemic therapeutic anticoagulation is uniformly recommended to minimize thromboembolic risk in patients treated with mechanical...
-
Immediate postoperative parenteral anticoagulant therapy in patients with mesenteric ischemia after intestinal resection: a retrospective cohort study at a single institute
BackgroundBowel gangrene represents a major fatal event in acute mesenteric ischemia. Intestinal resection is inevitable in patients with peritonitis...
-
Unapparent systemic effects of regional anticoagulation with citrate in continuous renal replacement therapy: a narrative review
The use of citrate, through reversible binding of calcium, has become the preferred choice for anticoagulation in continuous renal replacement...
-
Factor XI Inhibitors: A New Horizon in Anticoagulation Therapy
Anticoagulation therapy has undergone significant evolution, marked by the emergence of direct oral anticoagulants with distinct advantages. Despite...
-
Population-based study of long-term anticoagulation for treatment and secondary prophylaxis of venous thromboembolism in men with prostate cancer in Sweden
BackgroundEpidemiological data on anticoagulation for venous thromboembolism (VTE) in prostate cancer are sparse. We aimed to investigate...
-
Anticoagulation practices and complications associated with Impella® support at an advanced cardiac center in the Middle East gulf region
Anticoagulation during Impella® support is a challenge due to its complications and inconsistent practice across the globe. This observational,...
-
Direct oral anticoagulants versus standard anticoagulation in children treated for acute venous thromboembolism
AbstractDirect oral anticoagulants (DOACs) are widely used to treat venous thromboembolism (VTE) in adults. Little attention is given to pediatric...
-
Measurement of adherence and health-related quality of life during anticoagulation therapy in cancer-associated venous thromboembolism (VTE): a multicenter quantitative study
PurposeTherapy for cancer-associated venous thromboembolism (VTE) includes long-term anticoagulation, which may have substantial impact on the...
-
A simplified protocol of regional citrate anticoagulation with phosphate-containing solutions in infants and children treated with continuous kidney replacement therapy
BackgroundRegional citrate anticoagulation (RCA) is the preferred modality of anticoagulation used in continuous kidney replacement therapy (CKRT) in...
-
Regional citrate anticoagulation (RCA) in critically ill patients undergoing renal replacement therapy (RRT): expert opinion from the SIAARTI-SIN joint commission
Renal replacement therapies (RRT) are essential to support critically ill patients with severe acute kidney injury (AKI), providing control of...
-
Venous Thrombotic Events and Anticoagulation in Brain Tumor Patients
Purpose of ReviewBrain tumor patients have a 20–30% risk of venous thromboembolism (VTE), with management complicated by risk of intracranial...
-
How to assess hypercoagulability in heparin-induced thrombocytopenia? Biomarkers of potential value to support therapeutic intensity of non-heparin anticoagulation
BackgroundIn case of heparin-induced thrombocytopenia (HIT), the switch to a non-heparin anticoagulant is mandatory, at a therapeutic dose. Such a...
-
-
Anticoagulation in special patient populations with atrial fibrillation
Anticoagulation in patients with atrial fibrillation (AF) should be guided by considerations of the risk of thromboembolism, stroke, and bleeding as...
